CIK 0001447028 · Non-accelerated filer<br>Smaller reporting company
Arbutus Biopharma Corp
Sign in to watch- Ticker
- ABUS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- EIN
- 980597776
- Phone
- 604-419-3200
- Business address
- 701 VETERANS CIRCLE, WARMINSTER, PA, 18974
- Former names
- TEKMIRA PHARMACEUTICALS CORP, TEKMIRA PHARMACEUTICALS Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-01 | Beardsley Robert A Director | Returned to the company | −17,948 | $5.00 | $90K | 14,328 |
| 2026-10-01 | Nguyen Tuan Chief Financial Officer | Returned to the company | −48,081 | $5.00 | $240K | 111,882 |
| 2026-10-01 | Sawhney Roger Director | Returned to the company | −17,142 | $5.00 | $86K | 13,683 |
| 2026-10-01 | Androski Lindsay President and CEO | Returned to the company | −24,655 | $5.00 | $123K | 47,682 |
| 2026-10-01 | Roivant Sciences Ltd. Director | Returned to the company | −8,967,383 | $5.00 | $44.8M | 29,880,079 |
| 2026-09-18 | Androski Lindsay President and CEO | Option exercise | +116,408 | $3.20 | $373K | 144,408 |
| 2026-09-18 | Androski Lindsay President and CEO | Option exercise | +10,456 | $4.39 | $46K | 154,864 |
| 2026-09-18 | Androski Lindsay President and CEO | Shares withheld for taxes | −82,527 | $5.07 | $418K | 72,337 |
| 2026-09-18 | Androski Lindsay President and CEO | Option exercise · Stock Option (Right to Buy) | −116,408 | 194,014 | ||
| 2026-09-18 | Androski Lindsay President and CEO | Option exercise · Stock Option (Right to Buy) | −10,456 | 61,244 | ||
| 2026-09-18 | Nguyen Tuan Chief Financial Officer | Option exercise | +265,625 | $3.49 | $927K | 339,125 |
| 2026-09-18 | Nguyen Tuan Chief Financial Officer | Option exercise | +27,475 | $4.39 | $121K | 366,600 |
| 2026-09-18 | Nguyen Tuan Chief Financial Officer | Shares withheld for taxes | −206,637 | $5.07 | $1.0M | 159,963 |
| 2026-09-18 | Nguyen Tuan Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −265,625 | 484,375 | ||
| 2026-09-18 | Nguyen Tuan Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −27,475 | 160,925 | ||
| 2026-09-18 | Sawhney Roger Director | Option exercise | +52,533 | $3.34 | $175K | 52,533 |
| 2026-09-18 | Sawhney Roger Director | Option exercise | +78,800 | $4.24 | $334K | 131,333 |
| 2026-09-18 | Sawhney Roger Director | Shares withheld for taxes | −100,508 | $5.07 | $510K | 30,825 |
| 2026-09-18 | Sawhney Roger Director | Option exercise · Stock Option (Right to Buy) | −52,533 | 105,067 | ||
| 2026-09-18 | Sawhney Roger Director | Option exercise · Stock Option (Right to Buy) | −78,800 | 0 |
Page 1 of 8 · 141 trades